vTv Therapeutics
Price & Volume
Stats
See more52W Range | $12.62-$26.99 |
Market Cap | $58.4M |
Shares Short | 17,092 |
Financials
See moreRevenue (12 Mos) | $17,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$11.7M |
Diluted EPS | -$2.92 |
News
See moreYahoo Finance • 28 days ago
UPDATE -- vTv Therapeutics to Participate in Upcoming September Investor Conferences
Yahoo Finance • 2 months ago
VTV Therapeutics Inc-CL A (NASDAQ:VTVT) Reports Wider Q2 2025 Loss Amid Clinical-Stage Progress
Yahoo Finance • 2 months ago
vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Yahoo Finance • 2 months ago
vTv Therapeutics Announces USPTO Allowance of Patent Covering Cadisegliatin
About
CEO | Mr. Paul J. Sekhri M.Sc. |
CFO | Dr. Michael Steven Tung M.B.A., M.D. |
Address | 3980 Premier Drive, High Point, NC, United States, 27265 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 23 |
